I’m analyzing a longitudinal cohort of Multiple Myeloma patients’s ATACseq data, an NGS technique that allows the detection of open chromatin regions in a sample. To answer the biological question, I’m developing an innovative computational framework that allows the analysis of ATACseq data, taking into account the temporal evolution of cancer cells.